SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-13-000095
Filing Date
2013-08-19
Accepted
2013-08-19 16:19:39
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 june13form10qprotectvedgar1.htm 10-Q 252903
2 exhibit311.htm EX-31 9150
3 exhibit312.htm EX-31 9232
4 exhibit321.htm EX-32 4213
5 exhibit322.htm EX-32 4322
  Complete submission text file 0001551163-13-000095.txt   1126919

Data Files

Seq Description Document Type Size
6 prtt-20130630.xml EX-101.INS 37805
7 prtt-20130630.xsd EX-101.SCH 9101
8 prtt-20130630_cal.xml EX-101.CAL 13237
9 prtt-20130630_def.xml EX-101.DEF 6517
10 prtt-20130630_lab.xml EX-101.LAB 58536
11 prtt-20130630_pre.xml EX-101.PRE 47049
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 131048482
SIC: 2834 Pharmaceutical Preparations